Close
4

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Company profile for SHIRE VIROPHARM INC

    Client Virtual Booth

    SHIRE VIROPHARM INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    About the Company
    Contact SupplierContact Supplier
    Related CompaniesRelated Companies
    Since January 23, 2014, ViroPharma Inc. operates as a subsidiary of Shire Pharmaceutical Holdings Ireland Limited. ViroPharma Incorporated, a biotechnology company, develops and commercializes therapeutic products that address serious diseases in the United States and internationally. The company markets and sells Cinryze, a C1 esterase inhibitor therapy for the routine prophylaxis against angioedema attacks in adolescent and ...
    Since January 23, 2014, ViroPharma Inc. operates as a subsidiary of Shire Pharmaceutical Holdings Ireland Limited. ViroPharma Incorporated, a biotechnology company, develops and commercializes therapeutic products that address serious diseases in the United States and internationally. The company markets and sells Cinryze, a C1 esterase inhibitor therapy for the routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema, a life-threatening genetic disorder; and Vancocin HCl capsule, an oral capsule formulation for the treatment of C. difficile-associated diarrhea (CDAD) and to treat enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains. It also offers Plenadren, an orphan drug for treatment of adrenal insufficiency in adults; and Buccolam, an oromucosal solution for treatment of prolonged, acute, and convulsive seizures in infants, toddlers, children, and adolescents. The company’s development programs include Cinryze, a C1 esterase inhibitor for management of hereditary angioedema; maribavir for cytomegalovirus infection; and VP 20621, a non-toxigenic strain of C. difficile for the treatment and prevention of CDAD. Its clinical stage drug candidate comprises VP-20629 for the treatment of Friedreich’s Ataxia. The company sells its products directly to wholesale drug distributors and specialty pharmacies/distributors. It has a license agreement with GlaxoSmithKline to develop and commercialize maribavir, an antiviral compound. ViroPharma Incorporated was founded in 1994 and is headquartered in Exton, Pennsylvania.
    polpharma-m-2024-04-15

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    SHIRE VIROPHARM INC
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    730 Stockton Drive Exton, PA 19341
    Telephone
    Telephone
    +1 610-458-7300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search